Leukotrienes (LT) are lipid mediators of pulmonary inflammatory disorders. LTB4 stimulates adhesion of circulating neutrophils to vascular endothelium, directs their migration to sites of inflammation, and catalyzes the release of their granule constituents. It may produce hyperalgesia, myelopoiesis, and exert myotropic effects in some organs. The cysteinyl leukotrienes (LTC4, LTD4, and LTE4) constrict cardiac and bronchial smooth muscle and promote vascular permeability. Pathophysiology actions of leukotrienes are best understood in terms of their roles in immediate hypersensitivity and asthma. Roles in chronic inflammation associated with pulmonary disorders are likely, but not fully understood. Derangements in the cellular processes which govern the accumulation and disposition of LTA4, the pivotal biosynthetic intermediate in the leukotriene enzymatic pathway, are important in the pathogenesis of neutrophil-mediated lung damage. LTA4 hydrolase, a rate- limiting enzyme in the pathway is a critical determinant in the context. We have recently identified two types of LTA4 hydrolase inhibition: i) a constitutive process involving irreversible, mechanism-based inactivation which accompanies catalysis ii) a pharmacological process involving reversible inhibition by bestatin or captopril. We propose to evaluate selective modulation of LTA4 metabolism as a new pharmacological strategy for alleviating pulmonary inflammation. We also propose to determine what are the consequences of LTA4 accumulation on neutrophils when LTA4 hydrolase is inhibited. The results of our investigations will have direct implications for the therapeutic management of allergy and inflammatory pulmonary disorders. In four specific aims we plan to investigate: I. Effect of LTA4 Hydrolase Inhibition on Pulmonary Leukotriene Formation and Pulmonary Vascular Pressure in Isolated, Perfused Lungs. II. Regulation of 5-Lipoxygenase Activity by LTA4: Inactivation of 5- Lipoxygenase via Irreversible 'Feedback"""""""" Inhibition. III. Requirements for Substrate and Inhibitor Binding at the LTA4 Hydrolase/Aminopeptidase Active Site. IV. Affinity Chromatography Separation of Catalytically Active and 'Suicide' Inactivated Forms of LTA4 Hydrolase/Aminopeptidase: Development of an Assay to Detect Transcellular Leukotriene Biosynthesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI026730-04A2
Application #
2063505
Study Section
Lung Biology and Pathology Study Section (LBPA)
Project Start
1988-08-01
Project End
1997-08-31
Budget Start
1994-09-01
Budget End
1995-08-31
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Pharmacology
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Doyle, Kelly; Fitzpatrick, F A (2010) Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J Biol Chem 285:17417-24
Covey, Tracy M; Edes, Kornelia; Coombs, Gary S et al. (2010) Alkylation of the tumor suppressor PTEN activates Akt and ýý-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer. PLoS One 5:e13545
Wagner, Tracy M; Mullally, James E; Fitzpatrick, F A (2006) Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translati J Biol Chem 281:2598-604
Cassidy, Pamela B; Edes, Kornelia; Nelson, Chad C et al. (2006) Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis 27:2538-49
Moos, Philip J; Edes, Kornelia; Mullally, James E et al. (2004) Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 25:1611-7
Fitzpatrick, F A (2004) Cyclooxygenase enzymes: regulation and function. Curr Pharm Des 10:577-88
Yu, Margaret K; Moos, Philip J; Cassidy, Pamela et al. (2004) Conditional expression of 15-lipoxygenase-1 inhibits the selenoenzyme thioredoxin reductase: modulation of selenoproteins by lipoxygenase enzymes. J Biol Chem 279:28028-35
Verbitski, Sheryl M; Mullally, James E; Fitzpatrick, Frank A et al. (2004) Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity. J Med Chem 47:2062-70
Moos, Philip J; Edes, Kornelia; Cassidy, Pamela et al. (2003) Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J Biol Chem 278:745-50
Fitzpatrick, F A; Wheeler, Richard (2003) The immunopharmacology of paclitaxel (Taxol), docetaxel (Taxotere), and related agents. Int Immunopharmacol 3:1699-714

Showing the most recent 10 out of 29 publications